Market Overview

UPDATE: Deutsche Bank Reiterates Hold Rating, Lowers PT on Akorn

Related AKRX
Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio
Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon

In a report published Wednesday, Deutsche Bank reiterated its Hold rating on Akorn (NASDAQ: AKRX), but slightly lowered its price target from $14.00 to $13.00.

Deutsche Bank noted, “Q3 EPS A Penny Better– Benefiting from Lower R&D, Higher Gross Margin. Akorn reported Q3 cash EPS of $0.14, a penny ahead of both our and consensus ests, primarily due to modestly lower than forecasted R&D expenses (-$1.3M) and slightly better than projected gross margin of 57.6% (+80 bp vs our est). Nonetheless, while mgt continues to execute nicely on its plan, we maintain our HOLD rating on the co's shares in part due to our below consensus EPS ests for 2013 and 2014 and a valuation (5.4x 2012 revs) which still appears too ‘rich' for consolidators.”

Akorn closed on Tuesday at $12.38.

Latest Ratings for AKRX

Sep 2015NomuraInitiates Coverage onNeutral
Jul 2015SusquehannaInitiates Coverage onNeutral
Jul 2015SusquehannaInitiates Coverage onNeutral

View More Analyst Ratings for AKRX
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Price Target Analyst Ratings


Related Articles (AKRX)

Get Benzinga's Newsletters